Development
Xeriant, Inc.
XERI
$0.013
$0.00010.78%
OTC PK
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.36M | 1.61M | 2.05M | 3.03M | 3.71M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.44M | 1.63M | 2.05M | 3.09M | 3.78M |
Operating Income | -1.44M | -1.63M | -2.05M | -3.09M | -3.78M |
Income Before Tax | -2.53M | -2.62M | -7.10M | -9.60M | -12.02M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -2.53 | -2.62 | -7.10 | -9.60 | -12.02 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 30.50K | 30.10K | 29.60K | -619.50K | -619.30K |
Net Income | -2.50M | -2.59M | -7.07M | -10.22M | -12.64M |
EBIT | -1.44M | -1.63M | -2.05M | -3.09M | -3.78M |
EBITDA | -1.43M | -1.63M | -2.05M | -3.08M | -3.76M |
EPS Basic | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
EPS Diluted | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
Average Basic Shares Outstanding | 1.58B | 1.53B | 1.49B | 1.47B | 1.46B |
Average Diluted Shares Outstanding | 1.58B | 1.53B | 1.49B | 1.47B | 1.46B |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |